M ycetoMa was first described by Dr. John Gill, while working in Madura, India, in 1842 (as recounted by Ahmed et al.) . 1 This disease is subclassified into 2 categories ("actinomycosis" and "true mycetoma") according to the type of causative agent. Mycetoma is a pathological process in which eumycotic (fungal) or actinomycotic (bacterial) causative agents from an exogenous source produce grains. It is a localized, chronic, and deforming infectious disease of subcutaneous tissue, skin, and bones. It occurs in the so-called mycetoma belt stretching between the latitudes of 15° S and 30° N, and is endemic in relatively arid areas. 4 The organisms are present in the soil and may enter the subcutaneous tissue by traumatic inoculation. The infection then spreads through the fascial planes and destroys connective tissue and bone. In the bone, the cortex is invaded and masses of grains gradually replace osseous tissue and marrow. Poor personal hygiene, malnutrition, any history of trauma, wounds on bare feet, and multiple systemic infections may predispose an individual to the development of mycetoma, and it occurs mainly among farmers, herdsmen, field workers, and those who walk barefoot.
The clinical manifestation of mycetoma includes a triad of tumefaction, draining sinus tracts, and grain formation and extrusion. The most commonly affected site is the foot (70%); however, other exposed body parts such as the hand, leg, knee, arm, thigh, and perineum can be infected occasionally. 7 Craniofacial mycetoma is extremely rare, especially that caused by fungi, and is the most difficult form to treat. 7 Gumaa et al. 5 showed that mycetoma involving the head and neck accounted for 15 (3.75%) of 400 cases. An investigation by Lynch 10 indicated that the rate of cranial infection was only 3 of 317 cases in eumycetoma and 15 of 233 cases in actinomycetoma; that is, 15 of 18 mycetoma infections of the head were due to actinomycetes.
Craniocerebral mycetoma is extremely rare; only 2 cases have been reported so far in the world literature. We describe a case of maduromycetoma involving the right parietal cortex, overlying bone, and subcutaneous tissue. Interestingly, the previous 2 reports also involved the parietal lobe.
Case Report
History and Examination. This 17-year-old girl, who belonged to a farm family, presented with a 2-year history of recurrent generalized seizures, a progressively increasing right parietal scalp swelling for 3 months, and discharging sinus in the right parietal scalp wound for 2.5 months. There was no history of any obvious trauma or injury to the head or scalp. However, the patient reported a history of carrying wooden sticks on her head as a daily household routine. She also gave a history of incision and Craniocerebral maduromycetoma is extremely rare; only 2 cases have been reported so far. The authors report a case of maduromycetoma in a 17-year-old girl from a rural background in the state of Rajasthan, India, with involvement of the right parietal cortex, overlying bone, and subcutaneous tissue. The mass was totally excised, along with the involved dura mater, bone, and scalp. She was given antifungal drugs in the postoperative period. The patient responded very well to the treatment, and there were no signs of recurrence at the 6-month follow-up visit. The clinical features, imaging and histopathological investigations, and management of this rare entity are discussed, and the available literature is reviewed. The results of routine laboratory investigations were within normal limits, and the Western blot test was negative for HIV. Findings on the chest radiograph were normal, but the skull radiograph showed 2 well-defined radiolucent osteolytic areas in the right parietal region (Fig. 1A) . A CT scan of the brain obtained with contrast material revealed 2 well-defined, hyperdense, enhancing extraaxial lesions measuring 19 × 18 mm and 12 × 10 mm in the right parietal lobe, with scalloping and erosion of overlying parietal bone (Fig. 1B) and perilesional vasogenic edema. The patient underwent surgery for grosstotal removal of the lesion, along with the involved dura mater, bone, and scalp.
Operation and Postoperative Course. Subcutaneous pus and necrotic tissue with thick adhesions were noted intraoperatively. A black, well-defined lesion was noted to infiltrate the bone and dura mater and was invading the cerebral tissue. A craniotomy was done. The bone was thinned out and fragile and was infiltrated at some places. The dura was incised 2 cm away from the lesion. There was a good plane of cleavage between the lesion and the brain, except at some places the lesion was infiltrating the cerebral tissue. Gross-total excision of the lesion was done, along with the involved dura and the bone. Duraplasty was performed and the bone flap was replaced after obtaining a clean margin. The involved scalp was excised, and primary closure of the healthy scalp margins was done. Immediate and delayed postoperative periods were uneventful.
Histopathological Examination. On gross examination, the biopsy material was composed of brown-black, 2-to 4-mm grains admixed with pieces of gray-white, soft tissue. On microscopic examination, the grains were seen as rust-brown, oval colonies of long interlacing filamentous fungi (seen as negative shadows on H & E staining) embedded in a brown matrix (uniform cementlike material) and surrounded by neutrophilic exudates. The Splendore-Hoeppli phenomenon was not prominent. The gray-white, soft tissue showed brain parenchyma with fibrosis and dense inflammatory cell infiltrate on the meningeal surface. The inflammatory infiltrate was composed of neutrophils, lymphocytes, plasma cells, histiocytes, and foreign-body giant cells. Microabscess formation was also seen. The fungal hyphae were better seen in specimens prepared with PAS staining. Gomori methenamine-silver stain demonstrated the fungal colonies to be composed of radially arranged, septate filamentous hyphae, which were distributed throughout the grains. The dura mater and bone had similar histopathological results. The gross and microscopic findings in the lesion we describe are characteristic features of eumycotic mycetoma, which is also known as maduromycosis (Fig. 2) . Potassium hydroxide staining and fungal culture were not done because a fungal origin was not suspected pre-and intraoperatively. The patient began a course of the antifungal drugs voriconazole and terbinafine after the histopathological reports were received.
At her 6-month follow-up visit, the patient had no neurological deficits, she was seizure free on oral phenytoin therapy, and there was no discharging sinus. Postoperative MRI studies of the brain (obtained with contrast at 4 months) revealed gliosis at the surgical site (Fig. 3) . 
Discussion
Hickey 8 reported 3 instances of cranial maduromycetoma without penetration of the dura mater in 1950. One case involved the cranial vault quite extensively in a 20-year-old shepherd, and only a biopsy procedure was done (not excision). The other 2 cases, which occurred in a 30-year-old farmer and a 24-year-old shepherd, were sinocranial and involved the orbits and paranasal sinuses. In both cases, the lesion was surgically removed, necessitating enucleation of the eyeball in the farmer. Lynch 10 reported in 1964 that 3 of 18 mycetoma infections of the head were due to eumycetoma, of which only 1 was caused by Madurella mycetomatis.
The first reported case of eumycetoma (maduromycosis) involving the cerebral cortex in the English literature was reported by Natarajan et al. 13 in India in 1975. Their patient had a pyogenic brain abscess at the site of the cranial mycetoma ( The second reported case of maduromycosis involving the cerebral cortex was reported by Beeram et al. 2 in India in 2008; the causative organism was M. mycetomatis. Oral cavity mycetoma was reported by Nai et al. 12 in 2011. Mycetoma is more common in males; the male/female ratio ranges between 3:1 and 4:1.
3 This disease occurs mainly among farmers, herdsmen, field workers, and those who walk barefoot. In the 2 previously reported cases, the patients were young male farm laborers. Our patient was a young female belonging to a farm family in a rural area with an arid climate. Black-grain fungi cause eumycetoma in arid regions, whereas white-grain fungi cause eumycetoma in regions with higher rainfall and without a significant dry season. 3 In our case and in the 2 previously reported cases, maduromycoses (black-grain fungi) were present.
In addition, in our case and in the 2 previously reported cases, a history of seizure was present, whereas neurological deficit was only present in the case reported by Natarajan et al. 13 Seizures seem to be the most common symptom of craniocerebral maduromycosis. In the present case and in the previously reported ones, the lesion involved the parietal region; this seems to be the most common site of craniocerebral maduromycosis.
There are some conflicting reports about the role of the immune status of the susceptible population. Some investigators have reported partial impairment of the cellmediated immune response in severely infected patients or in those who do not respond to medical treatment. Eumycetoma has not been reported in HIV-infected patients. 3 The patient in our study was immunocompetent. In the maduromycoses, osteolytic changes predominate on radiographs, and although some sclerosis occurs around the lacunae produced, osteogenesis is usually not marked. The area of bone destruction characteristically forms circles or segments of circles simulating Gruyère cheese. In contrast, the bone lesion associated with actinomycosis shows a reticulated appearance due to osteolysis, but there is also marked osteogenic activity and often periosteal formation.
10 Purely osteolytic lesions with sclerotic changes are seen in the foot, whereas in the skull, changes are mainly sclerotic, with few osteolytic areas. 5 In our case, there were osteolytic lesions. A "dot in circle" sign on MRI studies is considered specific for mycetoma. 9 In the present case, a preoperative MRI study was not done.
In the past, the recommended treatment for localized eumycetoma due to M. mycetomatis was excision supplemented by griseofulvin and penicillin G procaine. 11 In the 2 previously reported cases of craniocerebral maduromycoses, neither streptomycin with penicillin (advocated by Natarajan et al. 13 ) nor itraconazole (advocated by Beeram et al. 2 ) could eliminate the fungus completely, and both patients continued to have discharging sinuses at follow-up. In his time, Hickey 8 had no medical treatment available at all. In our case, however, the patient was given voriconazole and terbinafine, and there was no discharging sinus on follow-up. The treatment of mycetoma is difficult, and failure is not uncommon. Generally, the response is better in cases of actinomycetoma than in eumycetoma. Early diagnosis followed by antifungal treatment in combination with excision appears to be a reasonable treatment.
Conclusions
Maduromycetoma involving the craniocerebrum [cranicerebral] is extremely rare. We report the third case of craniocerebral maduromycetoma. Although M. mycetomatis is the major cause of eumycetoma, little is known about its ecology, the most susceptible hosts, and hostpathogen interactions. This disease should be discussed by public health authorities and the scientific community, which can help in its early diagnosis and treatment.
